Table 2.
Average Values and Standard Deviations of the Anthropometric and Laboratory Findings Examined for the Whole Group and the Three Subgroups (Normal, Osteopenic, Osteoporotic Range) and Significance Levels (p Values) of One‐Way ANOVA
| Cohort (n = 93) | Osteoporosis (n 1 = 18) | Osteopenia (n 2 = 59) | Normal (n 3 = 16) | |
|---|---|---|---|---|
| Age (years) | 60.8 ± 4.2 | 62.3 ± 4.0 | 60.8 ± 4.2 | 59.1 ± 4.0 |
| BMI (kg/m2) | 22.9 ± 2.6 | a 21.6 ± 2.0 | 23.0 ± 2.7 | 23.9 ± 2.8 |
| Fat mass (kg) | 21.8 ± 4.9 | 20.0 ± 3.7 | 22.0 ± 5.0 | 22.8 ± 5.3 |
| Lean body mass (kg) | 31.6 ± 3.1 | a 30.1 ± 2.7 | 31.7 ± 3.2 | 32.8 ± 2.8 |
| 25(OH) D (nmol/L) | 59.9 ± 14.5 | 58.8 ± 14.4 | 60.0 ± 14.2 | 61.3 ± 16.3 |
| PTH (pmol/L) | 4.6 ± 1.3 | 4.5 ± 1.4 | 4.6 ± 1.3 | 4.8 ± 1.2 |
| Folate (nmol/L) | 35.6 ± 17.2 | a 28.8 ± 14.9 | 35.6 ± 15.8 | 43.2 ± 21.7 |
| Vitamin B‐12 (ng/mL) | 313.6 ± 139.4 | 277.1 ± 121.5 | 313.5 ± 120.3 | 343.9 ± 186.8 |
| HOMA‐IR | 1.34 ± 0.71 | 1.32 ± 0.77 | 1.33 ± 0.57 | 1.41 ± 0.70 |
HOMA‐IR = Homeostasis model assessment for insulin resistance.
a
Significantly lower than the normal BMD group.